MNTA—You ready to chime in yet about the Day-1 [Copaxone mini-trial] comments from Jeffries?
The Jefferies analyst didn’t say anything surprising, IMO. I’ve been saying all along that prevailing on the inequitable conduct argument will be tough (#msg-63619477).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”